The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
Contributing to effective and innovative cervical cancer screening, including direct treatment for women in resource-poor or hard-to-reach settings in the world.
Research
Contributing to effective and innovative cervical cancer screening, including direct treatment for women in resource-poor or hard-to-reach settings in the world.
Cervical cancer is a major public health problem, with annually more than 500.000 women worldwide diagnosed with this disease. With the Prevention and Screening Innovation Project towards Elimination of Cervical Cancer (PRESCRIP-TEC) we contribute to effective and innovative cervical cancer screening, including direct treatment for women in resource-poor or hard-to-reach settings in the world.
With PRESCRIP-TEC we conduct implementation research in four countries over three continents: Bangladesh and India in Asia, Uganda in Africa, and Slovakia in Eastern Europe. We will improve existing screening protocols in the four countries. In this research universities, cancer institutes and non-governmental organisations from these countries collaborate with the University Medical Center Groningen and the Female Cancer Foundation in the Netherlands.
Get to Know PRESCRIP-TEC in 2 minutes
Play video
Video
To view this content, please accept our social media cookies
Video bekijken
Scannen
Relevance
Improving coverage of cervical cancer screening
We study and address the barriers and facilitators of providing state-of-the-art community-based screening, treatment, and follow-up programme for cervical cancer in selected settings in Bangladesh, India, Uganda, and Slovak Republic. We measure coverage and uptake in relation to availability, accessibility, acceptability, quality and cost-effectiveness, and options for scaling up. The implementation research will focus on best ways to increase participation and compliance in cervical cancer screening (on the beneficiaries’ side) and improve implementation fidelity (on the providers’ side).
We will use an artificial intelligence decision support systems (AI-DSS) in gynaecological examination. The use of artificial intelligence built into mobile devices offers high quality diagnosis in resource-poor settings. Inter-observer variation in Visual Inspection of the cervix with Acetic acid (VIA) will be reduced, especially when health workers with lower levels of training are involved in the screening process.
Timeline
UMCG bachelor students participate in PRECRIP-TEC project in Bangladesh
Posted ago
In April and May 2022 the research team in Bangladesh performed a
survey into knowledge, practices and attitudes of rural women and men,
concerning cervical cancer, prevention and screening. Three medical
students from UMCG participated in the training of field workers and
assisted in the data collection in the field. They worked with the
Bangladeshi team for six weeks and travelled by boat to remote areas
in Bangladesh. In total, over 600 women and men were interviewed.
They helped with the data analysis and produced a Bachelor thesis for
their medical studies. This study will help the PRESCRIP-TEC project
in strengthening the communication and community mobilisation to
achieve maximum participation in the HPV self-testing and (if
necessary) follow-up screening by visual inspection of the cervix.
The same study was performed in Uganda, India and Slovakia. The
multi-country study gives insights into country-specific context to be
taken into account in rolling out HPV testing programmes.
In Uganda another team of medical students from UMCG worked in the
field with a local research team.
One year of the Cervical Cancer Elimination movement
Posted ago
On 17 Wednesday November 2021, we marked the first anniversary of the
first time the world has committed to eliminating a specific type of
cancer: Cervical Cancer.
One year ago countries and communities across the globe engaged in
the Cervical Cancer Elimination movement with a day of action. Over 100 landmarks
litt in the color teal – the color for the cervical cancer
elimination movement. In addition, cervical cancer survivors shared
their stories, public health experts played leading roles, and
ambassadors of the cause represented a broad coalition of partners
dedicated to eliminating cervical cancer.
On this day the World Health Organization (WHO) also launched a
global strategy to accelerate the elimination of cervical cancer
as a public health problem, with a resolution passed by 194 countries.
Dr. Jaap Koot about the importance of the PRESCRIP-TEC project
Posted ago
At the International Student Congress of (bio)Medical Sciences
(ISCOMS) Dr. Jaap Koot spoke about why the PRESCRIP-TEC project is
needed and important in preventing women from getting cervical cancer.
Towards Elimination of Cervical Cancer
Play video
Video
To view this content, please accept our social media cookies
Video bekijken
Scannen
Nomination for PRESCRIP-TEC
Posted ago
PRESCRIP-TEC is nominated for the Dutch Computable Awards 2021 in the
Care Project category. The jury calls the project an 'innovative
approach to pressing problems with clearly quantifiable effects'.
Video bekijken Scannen
